1. Home
  2. GOSS vs YRD Comparison

GOSS vs YRD Comparison

Compare GOSS & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • YRD
  • Stock Information
  • Founded
  • GOSS 2015
  • YRD 2012
  • Country
  • GOSS United States
  • YRD China
  • Employees
  • GOSS N/A
  • YRD N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • YRD Finance: Consumer Services
  • Sector
  • GOSS Health Care
  • YRD Finance
  • Exchange
  • GOSS Nasdaq
  • YRD Nasdaq
  • Market Cap
  • GOSS 586.6M
  • YRD 532.3M
  • IPO Year
  • GOSS 2019
  • YRD 2015
  • Fundamental
  • Price
  • GOSS $2.94
  • YRD $5.73
  • Analyst Decision
  • GOSS Strong Buy
  • YRD
  • Analyst Count
  • GOSS 4
  • YRD 0
  • Target Price
  • GOSS $8.50
  • YRD N/A
  • AVG Volume (30 Days)
  • GOSS 3.3M
  • YRD 88.0K
  • Earning Date
  • GOSS 11-06-2025
  • YRD 08-21-2025
  • Dividend Yield
  • GOSS N/A
  • YRD 7.68%
  • EPS Growth
  • GOSS N/A
  • YRD N/A
  • EPS
  • GOSS N/A
  • YRD 2.07
  • Revenue
  • GOSS $40,237,000.00
  • YRD $856,794,857.00
  • Revenue This Year
  • GOSS N/A
  • YRD N/A
  • Revenue Next Year
  • GOSS $30.65
  • YRD N/A
  • P/E Ratio
  • GOSS N/A
  • YRD $2.76
  • Revenue Growth
  • GOSS N/A
  • YRD 12.42
  • 52 Week Low
  • GOSS $0.66
  • YRD $4.37
  • 52 Week High
  • GOSS $2.98
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 76.74
  • YRD 41.97
  • Support Level
  • GOSS $2.41
  • YRD $5.71
  • Resistance Level
  • GOSS $2.71
  • YRD $6.35
  • Average True Range (ATR)
  • GOSS 0.19
  • YRD 0.18
  • MACD
  • GOSS 0.04
  • YRD -0.02
  • Stochastic Oscillator
  • GOSS 96.37
  • YRD 4.38

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: